Notice convening the Extraordinary General Meeting of Episurf Medical AB (publ)

The shareholders of Episurf Medical AB (publ), reg. no. 556767-0541 ("Episurf" or the "Company"), are hereby given notice to attend the Extraordinary General Meeting to be held on Thursday, 12 November 2026, at 15:00 (CET) at Episurf's office at Karlavägen 60, SE-114 49 Stockholm, Sweden. The entrance opens at 14:30 (CET). The Board of Directors has, pursuant to Chapter 7, Section 4 a of the Swedish Companies Act (Sw. aktiebolagslagen (2005:551)) and the Company's articles…

• Release

The Board of Directors of Episurf has resolved to propose the approval of a transaction to the Extraordinary General Meeting

The Board of Directors of Episurf Medical AB (publ) (“Episurf“, or the “Company“) has taken note of a press release published by Ilija Batljan Invest AB (publ), reg. no 559053-5166 (“IBI“) on 9 October 2026, according to which IBI intends to make an offer to repurchase all bonds issued by IBI with ISIN SE0016101810 (the “Bonds“) in return for a cash payment equivalent to 100 percent of the outstanding nominal amount of the Bonds, together…

• Release

Conversion of convertibles in a nominal amount of SEK 9,279,911 to 206,220,244 Class B shares

On 1 October 2026, Episurf Medical AB (publ) (“Episurf“) issued, in relation to the closing of the acquisition of the Hudiksvall portfolio, convertibles in an aggregated nominal amount of SEK 64,780,000. Convertibles in a nominal amount of SEK 9,279,911 have, as of the date of this press release, at the request from holders of convertible debentures, been converted into 206,220,244 Class B shares in Episurf at a conversion price of SEK 0.045 per share in…

The Board of Directors of Episurf has resolved on an issue of Class B shares and convertibles as consideration for the acquisition of properties and completed a conversion of convertibles

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, ISRAEL, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, THE UNITED KINGDOM, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR DISCLOSURE WOULD BE IN VIOLATION OF APPLICABLE LAWS OR REQUIRE ADDITIONAL REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO THE SECTION “IMPORTANT INFORMATION” AT THE END OF…

Episurf Medical completes acquisition of property portfolio in Hudiksvall

Episurf Medical AB (publ) (Nasdaq Stockholm: EPIS B) (“Episurf” or the “Company”) has today, through a wholly owned subsidiary, completed the acquisition of eight properties in Hudiksvall with an agreed underlying property value of SEK 300 million. With the exception of the property Åvik 26:14, the properties constitute the Non-completed Property Portfolio described in the Company’s press release of 30 December 2025. The properties have a total leasable area of approximately 16,300 m², annual rental…

Change in number of shares and votes in Episurf Medical

As a result of, in accordance with previously announced information, the directed issue of 3,303,407,120 Class B shares resolved on 31 August 2026 as well as the directed issue of an additional number of 1,000,000,000 Class B shares resolved on 31 August 2026, the number of shares and votes in Episurf Medical AB (publ) (“Episurf”) has changed.  Through the above-mentioned changes, the total number of shares in Episurf amounts to 14,991,836,513, of which 473,357 are…

• Episurf_Change in number of shares_202609

Episurf Medical enters into letter of intent regarding acquisition of property in Greater Stockholm of approximately SEK 95 million

Episurf Medical AB (publ) (”Episurf” or the ”Company”) has today entered into a letter of intent regarding the acquisition of all shares in LC Åkersberga Fastighets AB, a wholly-owned subsidiary of Landsort Care 4 AB and owner of the property Åkersberga Berga 11:47. The agreed underlying property value amounts to approximately SEK 95 million before deduction of deferred tax. The acquisition supports the Company’s strategy to build a Nordic property platform focused on cash flow generating assets and long-term value creation.  The property is fully let…

Episurf Medical enters into a property management agreement with Newsec

Episurf Medical AB (publ) (Nasdaq Stockholm: EPIS B) has entered into an agreement with Newsec regarding the management of the company’s growing property portfolio. The assignment comprises technical and operational property management, letting, financial management and advisory services in development and investment projects. Episurf Medical has, over a short period of time, built up a significant property portfolio through several acquisitions. To meet the continued expansion, the company has selected Newsec as its external management…

Episurf Medical enters the Finnish property market with the acquisition of logistics properties in the Helsinki area for EUR 33.6 mn

Episurf Medical AB (publ) ("Episurf" or the "Company") has acquired two logistics and warehouse properties in Helsinki and Kerava for EUR 33.6 mn from Julius Tallberg-Kiinteistöt. The share purchase agreement was signed and closing took place simultaneously. The properties comprise approximately 27,000 sqm and are let to strong tenants, including Gigantti Oy Ab and TIP Trailer Services Finland Ab, with a weighted average unexpired lease term (WAULT) of 3.4 years.  The properties are expected to generate annual net operating income (NOI) of approximately EUR 2.5 mn, reflecting a…